Compare StocksABBV vs EXPE

AbbVie Inc. (ABBV) vs Expedia Group, Inc. (EXPE): Which Is the Better Buy in 2026?

As of 2026-06-21, ABBV is overvalued at $216, with a DCF intrinsic value of $160 and a margin of safety of -35%. EXPE is undervalued at $241, with an intrinsic value of $437 and a margin of safety of 45%. Of the two, EXPE has the wider margin of safety.

ABBV
AbbVie Inc.
$216.49
VS
EXPE
Expedia Group, Inc.
$240.90

Rewards

ABBV
  • AbbVie Inc. has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • Gross margin of 72.0% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • AbbVie Inc. scores 82/100 on the Economic Moat Score (Wide Moat), with reinvestment efficiency as the strongest competitive dimension.
EXPE
  • Gross margin of 90.3% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • Expedia Group, Inc. scores 80/100 on the Economic Moat Score (Wide Moat), with revenue predictability as the strongest competitive dimension.
  • Share count has been reduced by 20% over the past 4 years through buybacks, increasing each share's claim on earnings.

Risks

ABBV
  • Buybacks have been poorly timed — 3 out of 4 years involved repurchases at relatively expensive valuations.
  • FCF yield of 5.4% suggests reasonable valuation assuming continued moderate growth.
  • Trailing P/E of 106.1x is 70% above the historical average of 62.3x — the stock trades at a premium to its own history.
EXPE
  • Altman Z-Score of 1.72 places the company in the distress zone — financial patterns resemble those of companies that experienced bankruptcy.
  • 10 insider sales with no purchases over the past 12 months — a persistent pattern of insider selling.

Key Valuation Metrics

Learn more →
ABBV
EXPE
Valuation
$20.81B
Free Cash Flow
$3.48B
5.44%
FCF Yield
12.03%
106.12
Trailing P/E
21.28
13.32
Forward P/E
10.43
Quality & Moat
21.89%
ROIC
12.99%
N/A
ROE
71.49%
72.03%
Gross Margin
90.27%
0.60
PEG Ratio
0.79
Balance Sheet Safety
N/A
Net Debt / Equity
Net cash
N/A
Interest Coverage
N/A
2.12
Net Debt / EBITDA
-0.42
3.20%
Dividend Yield
0.73%
ABBV: 4Ties: 1EXPE: 5
ABBVEXPE

Historical Fundamentals

Learn more →
ABBV

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

EXPE

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
ABBV
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-19.85B
Δ Market Cap
+$118.02B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
EXPE
$6.81
created per $1 retained over 3 years
Exceptional Value Creator
Σ Retained
$3.13B
Δ Market Cap
+$21.28B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
ABBV
35.3% Overvalued
Price is 35.3% above estimated fair value
Current Price: $216.49
Fair Value: $160.05
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
EXPE
44.8% Margin of Safety
Price is 44.8% below estimated fair value
Current Price: $240.90
Fair Value: $436.55
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
ABBV

What growth rate is the market pricing in at $216?

+17.1%
Market-Implied Owner Earnings Growth
Standard FCF implies +8.7%

The market implies +17.1% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +8.7%, reflecting heavy growth investment.

EXPE

What growth rate is the market pricing in at $241?

+7.5%
Market-Implied Owner Earnings Growth
Standard FCF implies -5.0%

The market implies +7.5% Owner Earnings growth, below historical trends — potential opportunity.

Standard FCF implies a more demanding -5.0%, reflecting heavy growth investment expected to generate future returns.

Economic Moat Score

Learn more →
ABBV
82/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. Reinvestment Efficiency is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
EXPE
80/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. Revenue Predictability is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

Forensic Accounting

Learn more →
ABBV
-2.86
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
EXPE
-2.74
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
ABBV
Insiders 0.1%Institutions 76.8%Retail & Other 23.0%
No. of Institutional Holders5,110
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
EXPE
Insiders 0.6%Institutions 104.3%
No. of Institutional Holders1,539
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
ABBV
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises
EXPE
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
ABBV
0
Sells (3M)
5
Sells (12M)
Total value (12M): $21.79M
PURDUE DAVID R.
Officer
$1.22M
@ $233.56 · 2026-03-04
SIATIS PERRY C.
General Counsel
$4.38M
@ $234.39 · 2026-03-02
SIATIS PERRY C.
General Counsel
$5.15M
@ $230.00 · 2026-02-25
SALEKI-GERHARDT AZITA
Chief Operating Officer
$8.41M
@ $198.42 · 2025-08-12
DONOGHOE NICHOLAS
Officer
$2.64M
@ $198.51 · 2025-08-05
STEWART JEFFREY RYAN
Officer
$12.36M
@ $210.08 · 2025-03-31
REENTS SCOTT T.
Chief Financial Officer
$3.75M
@ $212.34 · 2025-03-14
GONZALEZ RICHARD A
Director
$20.26M
@ $205.45 · 2025-03-03
SIATIS PERRY C.
General Counsel
$5.82M
@ $208.69 · 2025-03-03
RICHMOND TIMOTHY J
Officer
$4.47M
@ $210.45 · 2025-03-03
BUCKBEE KEVIN K
Officer
$3.85M
@ $203.41 · 2025-02-26
RICHMOND TIMOTHY J
Officer
$6.07M
@ $202.90 · 2025-02-26
SIATIS PERRY C.
General Counsel
$1.14M
@ $197.90 · 2025-02-20
BUCKBEE KEVIN K
Officer
$310,032
@ $172.24 · 2024-12-16
GONZALEZ RICHARD A
Officer and Director
$12.40M
@ $186.52 · 2024-08-05
GONZALEZ RICHARD A
Officer and Director
$49.50M
@ $175.00 · 2024-07-17
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
EXPE
2
Sells (3M)
10
Sells (12M)
Total value (12M): $6.63M
DZIELAK ROBERT J
Officer
$1.10M
@ $233.00 · 2026-06-05
SOLIDAY LANCE A
Officer
$208,547
@ $221.86 · 2026-05-26
DZIELAK ROBERT J
Officer
$1.82M
@ $220.82 · 2026-03-04
BANERJEE MADHUMITA MOINA
Director
$258,000
@ $258.00 · 2025-12-01
SOLIDAY LANCE A
Officer
$219,932
@ $256.93 · 2025-11-25
SOLIDAY LANCE A
Officer
$210,620
@ $248.08 · 2025-11-21
JACOBSON CRAIG A
Director
$814,650
@ $271.55 · 2025-11-13
SOLIDAY LANCE A
Officer
$175,412
@ $205.88 · 2025-08-20
JACOBSON CRAIG A
Director
$623,329
@ $207.78 · 2025-08-19
DZIELAK ROBERT J
Officer
$1.21M
@ $202.95 · 2025-08-13
SOLIDAY LANCE A
Officer
$132,098
@ $191.17 · 2025-03-04
KHOSROWSHAHI DARA
Director
$1.96M
@ $196.27 · 2025-03-03
DZIELAK ROBERT J
Officer
$1.03M
@ $205.70 · 2025-02-19
DZIELAK ROBERT J
Officer
$988,407
@ $203.00 · 2025-02-12
KHOSROWSHAHI DARA
Director
$1.70M
@ $169.79 · 2025-02-03
KHOSROWSHAHI DARA
Director
$1.85M
@ $185.15 · 2025-01-02
KHOSROWSHAHI DARA
Director
$1.85M
@ $184.66 · 2024-12-02
SOLIDAY LANCE A
Officer
$135,189
@ $185.95 · 2024-11-22
DZIELAK ROBERT J
Officer
$1.01M
@ $183.24 · 2024-11-22
SOLIDAY LANCE A
Officer
$1.27M
@ $181.99 · 2024-11-14
GORIN ARIANE
Chief Executive Officer
$10.37M
@ $181.14 · 2024-11-12
KHOSROWSHAHI DARA
Director
$1.57M
@ $156.87 · 2024-11-01
KHOSROWSHAHI DARA
Director
$1.50M
@ $150.18 · 2024-10-04
KHOSROWSHAHI DARA
Director
$1.50M
@ $150.21 · 2024-09-27
SOLIDAY LANCE A
Officer
$770,454
@ $134.58 · 2024-08-19
DZIELAK ROBERT J
Officer
$729,138
@ $134.60 · 2024-08-19
DZIELAK ROBERT J
Officer
$6.05M
@ $131.94 · 2024-08-15
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
ABBV
FearGreed
😐Neutral(56/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
EXPE
FearGreed
😐Neutral(47/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
ABBV
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (56)
EXPE
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (47)
View ABBV Full AnalysisView EXPE Full Analysis

Frequently Asked Questions: ABBV vs EXPE

Is AbbVie Inc. or Expedia Group, Inc. more undervalued in 2026?

Based on our discounted cash flow model, EXPE trades at a 44.8% margin of safety (intrinsic value $437 vs. price $241), compared to ABBV's -35.3% margin of safety (intrinsic $160 vs. $216).

Which stock has a wider economic moat, AbbVie Inc. or Expedia Group, Inc.?

ABBV scores 82/100 (Wide moat), while EXPE scores 80/100 (Wide moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is Expedia Group, Inc. in financial distress?

EXPE's Altman Z-Score of 1.7 places it in the Distress zone, signaling elevated bankruptcy risk. ABBV scores 2.4 (Grey zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which company has better free cash flow, AbbVie Inc. or Expedia Group, Inc.?

Expedia Group, Inc. (EXPE) generates a 12.0% free cash flow yield, compared to AbbVie Inc.'s 5.4%. A higher FCF yield means the business converts more of its market value into cash that can be returned to shareholders or reinvested.

Which stock has higher return on invested capital, AbbVie Inc. or Expedia Group, Inc.?

ABBV earns 21.9% ROIC versus EXPE's 13.0%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, AbbVie Inc.'s or Expedia Group, Inc.'s?

EXPE's dividend earns a safety score of 85/100 (Very Safe), compared to ABBV's 39/100 (Unsafe). EXPE has raised its dividend for 0 consecutive years.